about
Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vesselsRole of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1A new cytokine (IK) down-regulating HLA class II: monoclonal antibodies, cloning and chromosome localizationCharacterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elementsOrganization of the human CD9 geneLoss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature miceRole of Gas6 in erythropoiesis and anemia in miceRole of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapyA transgenic Xenopus laevis reporter model to study lymphangiogenesis.Thrombomodulin mutations in atypical hemolytic-uremic syndrome.Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins.Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulationsIdentification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosisRole of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles.OMSim: a simulator for optical map data.Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factorNuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation.Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes.p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.Induction of unresponsiveness to tumor necrosis factor (TNF) after autocrine TNF expression requires TNF membrane retention.TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis.How interleukin-2 can affect human fibroblasts behaviour.The IL-2 receptor present on human embryonic fibroblasts is functional in the absence of P64/IL-2R gamma chain.Human melanoma cell line M14 secretes a functional interleukin 2.Replication of human immunodeficiency virus in HL-60 cells.Fibrinolysis-independent role of plasmin and its activators in the haematopoietic recovery after myeloablation.The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter.Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6.Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.Effect of retinoic acid on HL-60 cells infected with human immunodeficiency virus type 1.VEGF: a modifier of the del22q11 (DiGeorge) syndrome?The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis.Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase.A genetic Xenopus laevis tadpole model to study lymphangiogenesis.Molecular cloning of the mouse equivalent of CD9 antigen.Genome dynamics of the human embryonic kidney 293 (HEK293) lineage in response to cell biology manipulationsHuman melanoma cells express a functional interleukin-2 receptorPurification and characterization of a factor which inhibits retrovirus replicationExpression of IL-2 receptors in human melanoma cellsElimination of a human T-cell region in staphylokinase by T-cell screening and computer modeling
P50
Q24299513-7937B398-8761-4BA6-94A1-A7919E7458F0Q24304277-0124F4A0-9582-4CE8-94F6-7A4EDB86D784Q24308099-E63417F1-CE4B-4A17-8657-C7C202030381Q24313300-3F6E28B4-6F57-41A9-BE69-97BC21C61215Q28268750-31123523-1C84-4999-94C6-B3F1C3143EB6Q28508637-506271F7-B212-4E1F-9F83-70D4FCA12201Q28513935-5636264A-973E-42A7-B473-F1DD6F56DFC4Q28584706-1FEACD63-E181-4244-A557-EDAF911597CBQ30544814-AE89FAB1-B9A3-400E-A58B-82D2E2FA09CDQ33385474-719E6AAA-D32C-4B98-85C8-46494539A5A6Q34184913-37F229FD-B648-4356-A966-1BE807472EDCQ34200605-60F12FA2-4859-434B-AD46-9E8CF14EB97AQ34243876-E8ED2984-2077-415D-8A17-1E4B8A852EB6Q34778250-203BDF3B-675C-4D68-934A-31FAB147C51CQ36363365-5968EA7D-BDC2-4A6B-BDBD-8CA65271A1E9Q36569110-67E8F202-A33E-4916-9AA1-960272A09C6DQ38723653-D3345CD5-BE54-493D-814D-C18A0A07F438Q40031486-E57E1C80-FEB0-4909-9CAB-FD147ACD64A4Q41062073-D9B1A6F9-EF3C-44AF-AC20-5B332BA0DA23Q41062078-5CA35D0D-0CB8-4AD7-84DD-50B88E1BA60BQ41206999-61D1129E-45CA-437E-A487-28E93CB94807Q41438837-60F7808E-7DCB-4EDA-8F3B-81EA6E797139Q41539463-C4937BF1-17F8-44B5-99C4-C9ABE50C7D1CQ41546076-3D0882DD-4E70-48E1-85C9-0EE768F4C8DBQ41616478-2B51700C-0A8B-41FC-98A9-BEC3B513109AQ42389714-D510886E-9C26-4560-9D68-382AB0BA0C64Q42479390-AF955FE8-6B42-43F7-AC8F-C61D3BA030C4Q43228829-13FCD302-15EF-4459-96F6-3C4D0621450DQ44601747-2A2A53BF-5952-449A-BA4B-AA50CAF1E208Q45783064-BBDBA2C3-502D-4720-8C28-E69ED76C6374Q45857957-AE9C1CBA-DC40-4E1C-A125-034922796E7DQ45861457-4100F52B-AAD1-4551-A186-BF49A41ACA6DQ45864838-883652DB-D19B-4A0D-873A-D3471F2A5D11Q45886167-EBDE68BF-C77E-454B-B4BE-15C279B81C94Q48104196-9FFED782-DA39-4CA2-94C2-09050A35AE64Q57863277-EE29C0E6-3BCD-48F1-BC86-787D14C2D863Q58044988-6C6E2083-583C-47C3-80C6-51F2193CF8ACQ63383182-0249D97D-7259-42E9-A691-79F08613DB46Q72797308-0BEDA788-6520-4F98-B26A-5A70088AE3A0Q74090912-788EDCE3-5558-4C92-A9A0-61748690C3AC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephane Plaisance
@ast
Stephane Plaisance
@en
Stephane Plaisance
@es
Stephane Plaisance
@nl
Stephane Plaisance
@sl
type
label
Stephane Plaisance
@ast
Stephane Plaisance
@en
Stephane Plaisance
@es
Stephane Plaisance
@nl
Stephane Plaisance
@sl
prefLabel
Stephane Plaisance
@ast
Stephane Plaisance
@en
Stephane Plaisance
@es
Stephane Plaisance
@nl
Stephane Plaisance
@sl
P106
P21
P31
P496
0000-0002-1651-241X